1. What Do the Transcriptome and Proteome of Menstrual Blood-Derived Mesenchymal Stem Cells Tell Us about Endometriosis?
    Letícia B. C. Penariol et al, 2022, International Journal of Molecular Sciences CrossRef
  2. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
    Cheng-Chan Yu et al, 2020, Molecules CrossRef
  3. H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival
    Sayeh Saravi et al, 2020, Journal of Clinical Medicine CrossRef
  4. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy
    Xintao Gao et al, 2023, Journal of Medicinal Chemistry CrossRef
  5. Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of BRCA2 Status
    Sayeh Saravi et al, 2021, Cells CrossRef
  6. Expression of mTOR in normal and pathological conditions
    A Marques-Ramos et al, 2023, Molecular Cancer CrossRef
  7. Ribosome Biogenesis Serves as a Therapeutic Target for Treating Endometriosis and the Associated Complications
    Cherry Yin-Yi Chang et al, 2022, Biomedicines CrossRef
  8. Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients
    Thomas J. Carter et al, 2020, Cancers CrossRef
  9. Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
    Aeman Zahra et al, 2021, Journal of Clinical Medicine CrossRef
  10. Interplay Between mTOR and Hippo Signaling in the Ovary: Clinical Choice Guidance Between Different Gonadotropin Preparations for Better IVF
    Kyriaki Papageorgiou et al, 2021, Frontiers in Endocrinology CrossRef
  11. Kinase Inhibitors and Ovarian Cancer
    null Katopodis et al, 2019, Cancers CrossRef
  12. The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
    Tatiana S. Driva et al, 2022, International Journal of Molecular Sciences CrossRef
  13. Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer
    null Kumar et al, 2019, Cells CrossRef
  14. Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
    Juhi Kumar et al, 2019, Frontiers in Oncology CrossRef